Materials & Resources » Chemicals | Chem Tech Research Inc.

Chem Tech Research Inc. | Income Statement

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Sales/Revenue
15,362
17,164
17,713
20,346
20,982
Cost of Goods Sold (COGS) incl. D&A
10,704
12,283
13,356
15,115
13,611
Gross Income
4,657
4,882
4,357
5,232
7,370
SG&A Expense
4,206
4,346
5,118
4,508
9,967
EBIT
341
433
916
605
2,794
Unusual Expense
603
56
1,198
10
602
Non Operating Income/Expense
19
41
164
106
473
Interest Expense
262
468
628
1,002
2,107
Pretax Income
459
126
2,516
118
4,499
Income Tax
81
179
151
696
116
Consolidated Net Income
378
305
2,365
577
4,383
Net Income
378
305
2,365
577
4,383
Net Income After Extraordinaries
378
305
2,365
577
4,383
Net Income Available to Common
378
305
2,365
577
4,383
EPS (Basic)
34.67
28.00
266.67
51.00
366.00
Basic Shares Outstanding
11
11
9
11
12
EPS (Diluted)
34.91
28.11
266.69
50.22
365.98
Diluted Shares Outstanding
11
11
9
11
12
EBITDA
972
1,148
104
1,403
1,739
Other Operating Expense
111
103
155
118
198
Non-Operating Interest Income
47
64
63
182
531

About Chem Tech Research

View Profile
Address
27 Gyeonggang-ro
Namyangju GY 12244
Korea, Republic Of
Employees -
Website http://www.c-tri.co.kr
Updated 09/14/2018
Chem Tech Research, Inc. is a holding company, which manufactures pharmaceuticals and related products based on biotechnology. The company operates through the following divisions: Pharmaceuticals, Biotechnology and Green Chemistry. Its products include peptide and antiviral drugs, ionic liquids and zanamivir derivatives.